[go: up one dir, main page]

ATE342049T1 - Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen - Google Patents

Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen

Info

Publication number
ATE342049T1
ATE342049T1 AT00935455T AT00935455T ATE342049T1 AT E342049 T1 ATE342049 T1 AT E342049T1 AT 00935455 T AT00935455 T AT 00935455T AT 00935455 T AT00935455 T AT 00935455T AT E342049 T1 ATE342049 T1 AT E342049T1
Authority
AT
Austria
Prior art keywords
formulation
release
controlled
encapsuled
micro
Prior art date
Application number
AT00935455T
Other languages
English (en)
Inventor
Yoav Blatt
Eugene Kimmelman
David Cohen
Avner Rotman
Original Assignee
Bio Dar Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Dar Ltd filed Critical Bio Dar Ltd
Application granted granted Critical
Publication of ATE342049T1 publication Critical patent/ATE342049T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT00935455T 1999-06-07 2000-06-07 Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen ATE342049T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/327,752 US6340478B1 (en) 1999-06-07 1999-06-07 Microencapsulated and controlled-release herbal formulations

Publications (1)

Publication Number Publication Date
ATE342049T1 true ATE342049T1 (de) 2006-11-15

Family

ID=23277898

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00935455T ATE342049T1 (de) 1999-06-07 2000-06-07 Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen

Country Status (7)

Country Link
US (1) US6340478B1 (de)
EP (1) EP1278514B1 (de)
AT (1) ATE342049T1 (de)
AU (1) AU5099400A (de)
DE (1) DE60031307T2 (de)
ES (1) ES2273697T3 (de)
WO (1) WO2000074656A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL131508A (en) * 1999-08-19 2006-12-10 David Cohen Micronexulatory formulations and controlled dispersion of isoflavins from rich masses of sesame and other plants
DE10012569A1 (de) * 2000-03-15 2001-09-20 Finzelberg Gmbh & Co Kg Hartgelatinekapseln enthaltend retardierte Pflanzenextrakte und Verfahren zur Herstellung derselben
DE10158281A1 (de) * 2001-11-19 2003-05-28 Mediwirk Gmbh Pharmazeutisches Präparat
US20040208928A1 (en) * 2003-04-15 2004-10-21 Animal Technology Institute Taiwan Method for preparing an orally administrable formulation for controlled release
MXPA06003942A (es) * 2003-10-10 2006-07-05 Ethypharm Sa Microgranulos de liberacion sostenida que contienen extracto de gingko biloba, y procedimiento para la fabricacion de los mismos.
EP1602364A1 (de) * 2004-05-25 2005-12-07 Cognis IP Management GmbH Mikrokapseln (XXX), enthaltend Pflanzenextrakte, und Verfahren zu deren Herstellung
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
DK2060192T3 (en) * 2007-10-17 2016-02-22 Wild Gmbh & Co Kg Rudolf Composition comprising lemon balm extracts
US20090165578A1 (en) * 2007-12-06 2009-07-02 Pain Therapeutics, Inc. Dissolution test equipment and methods for testing
FR2952824B1 (fr) * 2009-11-23 2011-11-11 Aliou Mamadou Balde Composition antidiabetique contenant un extrait vegetal d'englerina lecardii
CH704253A1 (de) * 2010-12-21 2012-06-29 Mepha Gmbh Pharmazeutische Zusammensetzung enthaltend pflanzliche Wirkstoffe.
US11229600B2 (en) * 2014-09-24 2022-01-25 Vital Beverages Global Inc. Compositions and methods for selective GI tract delivery
GB201420306D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
GB201420311D0 (en) * 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
GB201420300D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Tablet

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
FR2715582B1 (fr) 1994-02-02 1996-03-15 Centre Nat Rech Scient Microcapsules à paroi de flavonoïde réticulée et compositions en contenant.
DE4434170C1 (de) 1994-09-24 1996-03-28 Krewel Werke Gmbh Johanniskrautextrakte
US5560928A (en) * 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
EP0922450B1 (de) * 1997-12-01 2003-04-23 Dr. Gergely & Co. Brausezubereitung enthaltend ein Pflanzenextrakt
US6270803B1 (en) * 1998-10-07 2001-08-07 Bio Dar Ltd. Controlled-release garlic formulations
AR020343A1 (es) * 1998-11-24 2002-05-08 Steigerwald Arzlneimittelwerk Metodo para producir farmacos que contienen extractos de plantas en una forma solida de aplicacion.

Also Published As

Publication number Publication date
EP1278514B1 (de) 2006-10-11
DE60031307T2 (de) 2007-05-24
EP1278514A1 (de) 2003-01-29
DE60031307D1 (de) 2006-11-23
AU5099400A (en) 2000-12-28
ES2273697T3 (es) 2007-05-16
WO2000074656A1 (en) 2000-12-14
US6340478B1 (en) 2002-01-22

Similar Documents

Publication Publication Date Title
ATE342049T1 (de) Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen
WO2004043513A3 (en) Surface dissolution and/or bulk erosion controlled release compositions and devices
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
CA2322315A1 (en) Fast disintegrating tablets
BR9503386A (pt) Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina
DK1073415T3 (da) Gelerbare farmaceutiske sammensætninger
ZA200500716B (en) Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
HUT48821A (en) Process for production of medical compositions
DE69730991D1 (de) Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung
NO307594B1 (no) Fremgangsmåte for fremstilling av en tørr, hydratisert cefalosporinpulverformulering, og farmsøytisk preparat
NO20010957L (no) Nye hydratformer av alendronatnatrium, fremgangsmåter for fremstilling av disse og farmasöytiske preparater derav
DK0711560T3 (da) Farmaceutisk sammensætning til oral indgivelse af flavonoider
PL321567A1 (en) Oral administration forms containing a beta-lactame antibiotic
JPH0657659B2 (ja) 消化管にて種々のレベルで消化促進剤として作用する酵素組成物
GB2359022A (en) Controlled-release garlic formulations
IL124858A0 (en) Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
DE69919003D1 (de) Acetaminophen-formulierung mit verlängerter freisetzung
CA2339931A1 (en) Extended release acetaminophen
HK1068282A1 (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for usein treatment of ulcerative colitis and crohn's di sease
GB9119052D0 (en) Pharmaceutical compositions
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
KR100349249B1 (ko) 단일 펠렛형 서방성 제제
YU20050411A (sh) Komopzicije oksikodona sa kontrolisanim oslobadanjem
HUP9902179A2 (hu) Hatóanyagként cisapridot tartalmazó PH-tól független, azonnali hatóanyag felszabadításra alkalmas szilárd gyógyszerkészítmény
BR9802588A (pt) Processo para preparação de composições granuladas contendo macrolìdeos de eritromicina e processo para preparação de composições farmaceuticas contendo ditos macrolìdeos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties